174 related articles for article (PubMed ID: 11407054)
1. Topical antibiotics for acute bacterial conjunctivitis: a systematic review.
Sheikh A; Hurwitz B
Br J Gen Pract; 2001 Jun; 51(467):473-7. PubMed ID: 11407054
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for acute bacterial conjunctivitis.
Sheikh A; Hurwitz B; Cave J
Cochrane Database Syst Rev; 2000; (2):CD001211. PubMed ID: 10796757
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics versus placebo for acute bacterial conjunctivitis.
Sheikh A; Hurwitz B
Cochrane Database Syst Rev; 2006 Apr; (2):CD001211. PubMed ID: 16625540
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics versus placebo for acute bacterial conjunctivitis.
Sheikh A; Hurwitz B; van Schayck CP; McLean S; Nurmatov U
Cochrane Database Syst Rev; 2012 Sep; (9):CD001211. PubMed ID: 22972049
[TBL] [Abstract][Full Text] [Related]
5. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update.
Sheikh A; Hurwitz B
Br J Gen Pract; 2005 Dec; 55(521):962-4. PubMed ID: 16378567
[TBL] [Abstract][Full Text] [Related]
6. [From the Cochrane Library: Marginally higher chance of cure by antibiotic treatment in acute bacterial conjunctivitis].
Hamerlynck JV; Rietveld RP; Hooft L
Ned Tijdschr Geneeskd; 2007 Mar; 151(10):594-6. PubMed ID: 17402650
[TBL] [Abstract][Full Text] [Related]
7. Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Wald ER; Greenberg D; Hoberman A
Pediatr Infect Dis J; 2001 Nov; 20(11):1039-42. PubMed ID: 11734708
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
Comstock TL; Paterno MR; Usner DW; Pichichero ME
Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
[TBL] [Abstract][Full Text] [Related]
9. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis.
Jefferis J; Perera R; Everitt H; van Weert H; Rietveld R; Glasziou P; Rose P
Br J Gen Pract; 2011 Sep; 61(590):e542-8. PubMed ID: 22152728
[TBL] [Abstract][Full Text] [Related]
10. Management strategies for acute infective conjunctivitis in primary care: a systematic review.
Rose P
Expert Opin Pharmacother; 2007 Aug; 8(12):1903-21. PubMed ID: 17696792
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
[TBL] [Abstract][Full Text] [Related]
12. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis.
Honkila M; Koskela U; Kontiokari T; Mattila ML; Kristo A; Valtonen R; Sarlin S; Paalanne N; Ikäheimo I; Pokka T; Uhari M; Renko M; Tapiainen T
JAMA Netw Open; 2022 Oct; 5(10):e2234459. PubMed ID: 36194412
[TBL] [Abstract][Full Text] [Related]
13. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
[TBL] [Abstract][Full Text] [Related]
14. Topical antibiotics for acute bacterial conjunctivitis.
Fleetcroft R
Br J Gen Pract; 2001 Aug; 51(469):673-4. PubMed ID: 11510404
[No Abstract] [Full Text] [Related]
15. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial.
Rose PW; Harnden A; Brueggemann AB; Perera R; Sheikh A; Crook D; Mant D
Lancet; 2005 Jul 2-8; 366(9479):37-43. PubMed ID: 15993231
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics Versus Placebo for Acute Bacterial Conjunctivitis: Findings From a Cochrane Systematic Review.
Liu SH; Chen YY; Nurmatov U; van Schayck OCP; Kuo IC
Am J Ophthalmol; 2024 Jan; 257():143-153. PubMed ID: 37482371
[TBL] [Abstract][Full Text] [Related]
18. The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial.
Rietveld RP; ter Riet G; Bindels PJ; Bink D; Sloos JH; van Weert HC
Br J Gen Pract; 2005 Dec; 55(521):924-30. PubMed ID: 16378561
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older.
Heller W; Cruz M; Bhagat YR; De Leon JM; Felix C; Villanueva L; Hollander DA; Jensen H
J Ocul Pharmacol Ther; 2014 Dec; 30(10):815-22. PubMed ID: 25244402
[TBL] [Abstract][Full Text] [Related]
20. Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to commercially available topical antibiotics in Nepal.
Shrestha SP; Khadka J; Pokhrel AK; Sathian B
Nepal J Ophthalmol; 2016 Jan; 8(15):23-35. PubMed ID: 28242882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
